Tigermed plans sale of Frontage's overseas laboratory business to Charles River, Song Li

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • Tigermed proposes to participate in the privatization of controlled subsidiary Frontage Holdings through wholly owned Hongkong Tigermed. * A subsequent restructuring would sell Frontage’s overseas laboratory services business to Charles River Laboratories, Frontage Chairman Song Li and his trusts. * Frontage’s China business would be retained, strengthening the group’s focus on clinical contract research services. * The transaction is expected to generate proceeds and investment gains for potential reinvestment in the core clinical research business. * Completion remains subject to relevant conditions and implementation requirements. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.